Toll-Interacting Protein Regulates Immune Cell Infiltration and Promotes Colitis-Associated Cancer.

Détails

Ressource 1Télécharger: 32114379_BIB_9F4D29F09585.pdf (34882.77 [Ko])
Etat: Public
Version: de l'auteur⸱e
Licence: CC BY-NC-ND 4.0
ID Serval
serval:BIB_9F4D29F09585
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Toll-Interacting Protein Regulates Immune Cell Infiltration and Promotes Colitis-Associated Cancer.
Périodique
iScience
Auteur⸱e⸱s
Begka C., Pattaroni C., Mooser C., Nancey S., McCoy K.D., Velin D., Maillard M.H.
Collaborateur⸱rice⸱s
Swiss IBD Cohort Study Group
ISSN
2589-0042 (Electronic)
ISSN-L
2589-0042
Statut éditorial
Publié
Date de publication
27/03/2020
Peer-reviewed
Oui
Volume
23
Numéro
3
Pages
100891
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
Expression of Toll-interacting protein (Tollip), a potent TLR modulator, decreases in patients with inflammatory bowel diseases (IBD), whereas Tollip <sup>-/-</sup> mice are susceptible to colitis. Tollip expression was shown to be reduced in sporadic adenoma. In contrast, we found variable Tollip expression in patients with colitis-associated adenomas. In Tollip <sup>-/-</sup> mice challenged to develop colitis-associated cancer (CAC), tumor formation was significantly reduced owing to decreased mucosal proliferative and apoptotic indexes. This protection was associated with blunt inflammatory responses without significant changes in microbial composition. mRNA expression of Cd62l and Ccr5 homing receptors was reduced in colons of untreated Tollip <sup>-/-</sup> mice, whereas CD62L <sup>+</sup> CD8 <sup>+</sup> T cells accumulated in the periphery. In Tollip-deficient adenomas Ctla-4 mRNA expression and tumor-infiltrating CD4 <sup>+</sup> Foxp3 <sup>+</sup> regulatory T cell (Treg) were decreased. Our data show that protection from CAC in Tollip-deficient mice is associated with defects in lymphocyte accumulation and composition in colitis-associated adenomas.
Mots-clé
Biological Sciences, Cancer, Immunology
Pubmed
Web of science
Open Access
Oui
Création de la notice
05/03/2020 15:37
Dernière modification de la notice
09/03/2023 6:49
Données d'usage